Showing results (81-90 of 370) with videos related to
Sort By:
Pageof 37
Journal of Neuro-Oncology|October 11, 2005
Metastasis to nervous system: spinal epidural and intramedullary metastasesMelike Mut, David Schiff, Mark E ShaffreyJournal of Neuro-Oncology|June 24, 2021
Incidence, risk factors and management of venous thromboembolism in patients with primary CNS lymphomaMiyabi Saito, Nolan A Wages, David SchiffNeuro-Oncology|February 20, 2010
Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and miceJohn F de Groot, Gregory Fuller, Ashok J Kumar, et al.International Journal of Molecular Sciences|March 19, 2020
Role of Neutrophils and Myeloid-Derived Suppressor Cells in Glioma Progression and Treatment ResistanceSabbir Khan, Sandeep Mittal, Kain McGee, et al.Neuro-Oncology|September 12, 2012
Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotypeYuji Piao, Ji Liang, Lindsay Holmes, et al.Journal of Neurology|May 27, 2014
Prolonged survival in adult neurofibromatosis type I patients with recurrent high-grade gliomas treated with bevacizumabBrett J Theeler, Benjamin Ellezam, Shlomit Yust-Katz, et al.Neuro-Oncology|March 12, 2016
Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse modelsYuji Piao, Soon Young Park, Verlene Henry, et al.The Lancet. Oncology|January 2, 2007
Part I: spinal-cord neoplasms-intradural neoplasmsDavid E Traul, Mark E Shaffrey, David SchiffPlos One|March 14, 2014
MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and METYing Zhang, David Schiff, Deric Park, et al.Neurologic Clinics|August 4, 2018
Neurologic and Medical Management of Brain TumorsKester A Phillips, Camilo E Fadul, David SchiffPageof 37